Scarlet Pimpernel (Anagallis arvensis)

Scarlet pimpernel (Anagallis arvensis) contains saponins, flavonoids, and cucurbitacins that drive its primary biological activities. These compounds inhibit cyclooxygenase enzymes (COX-1 and COX-2) and scavenge superoxide radicals, underpinning its traditional use in wound healing and infection management.

Category: European Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
Scarlet Pimpernel (Anagallis arvensis) — Hermetica Encyclopedia

Origin & History

Scarlet pimpernel, also known as Anagallis arvensis or Lysimachia arvensis, is an annual herbaceous plant native to Europe, western Asia, and northern Africa. It is commonly found in fields and disturbed areas and features small orange-red to blue flowers.

Historical & Cultural Context

In Navarra, Spain, Scarlet pimpernel has been used ethnomedicinally for wound healing and internal infections despite its known toxicity. It is also traditionally applied for various ailments like joint pain and liver disorders.

Health Benefits

• Antimicrobial activity against Candida albicans (in vitro) [3]. • Potential anti-inflammatory effects via COX-1 and COX-2 inhibition (in vitro) [3]. • Superoxide scavenging properties (in vitro) [3]. • Traditional use for wound healing in Navarra, Spain [3]. • Historical use in treating infections, though lacking scientific backing [5].

How It Works

Scarlet pimpernel's triterpenoid saponins and cucurbitacins inhibit COX-1 and COX-2 enzymes, reducing prostaglandin synthesis and dampening inflammatory cascades. Its flavonoid constituents, including luteolin and apigenin glycosides, donate hydrogen atoms to neutralize superoxide radicals, reducing oxidative stress at the cellular level. Antifungal activity against Candida albicans is attributed to saponin-mediated disruption of fungal membrane integrity, altering membrane permeability and ergosterol function.

Scientific Research

No human clinical trials or randomized controlled trials have been identified for Anagallis arvensis. The evidence is limited to preclinical in vitro studies, such as the study with PMID: 21237261, which explored antimicrobial and anti-inflammatory effects.

Clinical Summary

Available evidence for scarlet pimpernel is limited exclusively to in vitro studies, with no published human clinical trials or controlled animal studies establishing efficacy or dosing. In vitro assays have demonstrated inhibition of COX-1 and COX-2 enzymes and superoxide scavenging activity in plant extracts, though effect magnitudes and concentrations tested do not directly translate to human dosing. Antifungal activity against Candida albicans has been observed in laboratory settings, but no minimum inhibitory concentration data from standardized clinical panels has been widely replicated. Ethnobotanical records from Navarra, Spain document topical wound healing use, representing low-quality observational evidence that cannot establish causation or safety thresholds.

Nutritional Profile

Scarlet Pimpernel (Anagallis arvensis) has limited formal nutritional analysis, but the following compounds have been identified: Bioactive compounds include triterpenoid saponins (primulasaponin and related oleanolic acid glycosides), flavonoids including kaempferol and quercetin derivatives, and cucurbitacins (toxic tetracyclic triterpenoids that significantly limit edibility). Phenolic compounds including caffeic acid derivatives contribute to its antioxidant and antimicrobial properties. The plant contains anagallin (a flavonol glycoside) and cyclamin-type saponins. Tannins are present at moderate levels. Essential oils with terpenoid constituents have been detected in aerial parts. Regarding macronutrients: as a small leafy herb, it would contain predominantly water (~80-85% fresh weight), with modest fiber content typical of leafy plants (<2g/100g fresh weight), minimal protein, and negligible fat. No formal vitamin or mineral quantification data exists in peer-reviewed literature. Bioavailability is a significant concern: the presence of cucurbitacins renders the plant toxic in meaningful quantities, causing gastrointestinal irritation and potential neurotoxicity, severely restricting safe consumption. Saponins may also reduce mineral bioavailability through chelation. The plant is classified as toxic to humans and livestock by European regulatory standards, meaning its nutritional profile is largely academic — it is NOT considered a food ingredient in contemporary use and any historical culinary application was extremely limited.

Preparation & Dosage

No clinically studied dosage ranges exist for any form of Scarlet pimpernel due to the lack of human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ginger, Boswellia, Echinacea, Green Tea

Safety & Interactions

Scarlet pimpernel has a well-documented history of toxicity in livestock, caused by saponin content that can irritate mucous membranes and cause gastrointestinal distress, vomiting, and dermatitis in sensitive individuals at higher doses. The plant is considered potentially toxic when consumed in large quantities by humans, and internal use is not recommended without professional supervision. No formal drug interaction studies exist, but COX-inhibiting activity theoretically warrants caution alongside NSAIDs, anticoagulants such as warfarin, and antiplatelet medications. It is contraindicated in pregnancy due to historical use as an emmenagogue and abortifacient, and safety in breastfeeding has not been established.